Please login to the form below

Not currently logged in

rectal cancer

This page shows the latest rectal cancer news and features for those working in and with pharma, biotech and healthcare.

IBM teams up with Teva for global eHealth collaboration

IBM teams up with Teva for global eHealth collaboration

Willalso partner with ICON on cancer trials project.  . IBM has signed deals with Teva and ICON that will see the firms use services based on its Watson supercomputer. ... This will be applied to breast, lung, colon and rectal cancer trials and aims to

Latest news

  • Valeant and Shire said to be evaluating potential Salix bids Valeant and Shire said to be evaluating potential Salix bids

    Valeant currently in final stages of Provenge acquisition.  . Valeant Pharmaceuticals is in the final stages of acquiring Dendreon's cancer vaccine Provenge but is already lining up its next acquisition prospect, ... Nevertheless, in the latter half of

  • Close but no cigar

    Despite failure to show clinical benefit, gene therapy continues to offer hope for cancer treatment. ... TNFerade has also shown potential in the treatment of rectal cancer, head and neck cancer, metastatic melanoma and oesophageal cancer.

  • Roche and Pfizer report growth

    Sales of the osteoporosis drug Bonviva, and the cancer therapy Avastin, which were up 41 per cent and 37 per cent respectively, contributed to the successful sales story to date. ... cancer). US revenue has decreased by 13 per cent. However, the

  • Contraceptive pill may protect against cancer

    In the main dataset women on the pill had statistically significant lower rates of large bowel/rectal, uterine body and ovarian cancer. ... The GP dataset also showed a reduced risk of uterine and ovarian cancer.

  • Feverish activity

    Erbitux (cetuximab), originally developed by ImClone Systems, and licensed to Bristol-Myers Squibb and Merck KGaA, was approved for the treatment of colo-rectal cancer in 2004 and is currently undergoing ... Treatment of advanced prostate cancer. EU.

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch